BioWorld MedTech

Jan. 25, 2011

Deals roundup: Novartis to acquire Genoptix for nearly $470 million

Shares of Genoptix (Carlsbad, California) saw unusually high trading volume Monday, after Novartis (Basel, Switzerland) reported that it would acquire the company for $470 million. (Medical Device Daily) Read More

Midwest attracts $737M in new investments in 2010

Report from Europe: European Union seen driving bio-medical imaging network

Washington roundup: Alphatec hit with warning over 522 surveillance study

Financings roundup: Digital Assent reports closing $2M Series A funding round

Coming Wednesday in MDD Perspectives: Revenue at risk as non-qualifying patients receive med-tech products

HIT roundup: Merge Healthcare deploys iConnect Access at UHMC

People in the News

Med-Tech Notes

Patent watch: Biolase issued new patent for presbyopia/hyperopia

Agreements/contracts: KOL clients expand with Heartbeat Express

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...